Gambogenic acid is one of the main components of Gamboge which can be used in combination with 5-FU to upregulate necroptosis-related proteins such as RIP1 in lung cancer cells, thereby inducing necroptosis[67]. The gene discussed is RIPK1; the disease is lung carcinoma.